AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well AZD0530 works in treating patients with prostate
cancer that did not respond to hormone therapy. AZD0530 may stop the growth of tumor cells by
blocking some of the enzymes needed for cell growth